Medical Equipments, Pharmaceuticals And Personal Care Products Tenders

Medicines with the Active Ingredient Pipamperone (Atc: N05ad05)

Medicines with the Active Ingredient Flecainide (Atc: C01bc04)

Open Framework Agreement on Drug Discounts in Accordance with Section 130A Paragraph 8 Sgb V with the Possibility of Joining at any Time, So-Called Approval Model 2023-08

Medicines with the Active Ingredient Ambrisentan (Atc: C02kx02)

Medicines with the Active Ingredient Betahistine (Atc: N07ca01)

Market Dialogue Prior to Offering Products for Varicose Vein Treatment

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V (Open House Model)

Open House Contracts for Several Active Ingredients/Combinations of Active Ingredients

Conclusion not Excluding Drug Discount Agreement. According to Section 130A Paragraph 8 Sgb V through an Open House Model for the Active Ingredient Vilanterol/Fluticasone Furoate (Atc Code According t...

Conclusion not Excluding Drug Discount Agreement. According to Section 130A Paragraph 8 Sgb V through an Open House Model for the Active Ingredient Colistin (Atc Code According to Who: J01xb01)